Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by tuesdaynightridon Oct 30, 2015 12:02pm

122 Views

Post# 24243609

RE:RE:RE:Clinical experience and outcome of PDT in early lung cancer

As posted,

" if you think of the anatomy.. what best suits PDT
Lung, Bladder & Esophagus. Easily accessed
.... light can hit the lining of and into the structures."

Anyone here ever figure out why the Roger White requires the TLC-3200
(used to be the TLC-3000) to activate TLD-1433??
Photofrin, Laserpherin etc have all been activated via prior art
... this is not new science but he has not offerred any explanation to date
that I have heard.

P.s. This question is for anyone except bencro because I know you don't
have a clue and it will spare everyone here having to read thru your muddled,
off topic response.

Bullboard Posts

A junior copper-gold stock trading at a bargain of monumental proportions